Aurinia Pharmaceuticals

This page shows the latest Aurinia Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Lupus trial hailed as a success despite patient deaths

Phase IIb trial of Aurinia Pharmaceuticals’ voclosporin met its objective. A medical charity representing patients with lupus erythematosus has welcomed the results of a study showing the efficacy of a new ... The phase IIb trial of Aurinia

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

Bayer veteran joins Aurinia as CEO

Stephen Zaruby spent 20 years at German pharma company. Aurinia Pharmaceuticals has appointed Stepen Zaruby as president and CEO. ... Aurinia is well positioned to bring voclosporin forward as an important new treatment for lupus nephritis,” he said.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Working together against COVID-19: Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19: Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?: Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....